Repligen Stock Drops After-Hours Following $1 Billion Convertible Notes Sale
Repligen shares fell about 20% after hours following a $1 billion convertible notes deal, as reported by Dow Jones Newswires, which cited an SEC filing.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Repligen's stock lost roughly a fifth of its value in extended trading on Friday after the company placed $1 billion of convertible senior notes, Dow Jones Newswires reported. Shares were quoted near $138.99, down 20% from the $173.49 close, which itself marked a 3% gain on the session and a year-to-date rise of 5.9%.
The debt carries a 0.25% coupon and matures on November 1, 2031, based on a filing with the SEC. About $541.4 million of the new paper was swapped for roughly $456.8 million of the company's existing 1% notes due 2028, while the remaining $458.6 million was raised in cash. After the exchange, Repligen says $143.2 million of the 2028 notes remain outstanding.
why it matters
For a life-sciences tools maker, a large convertible deal raises questions about possible dilution and a changing debt load. The sharp reaction after the bell shows how sensitive investors are to financing moves of this kind.
market impact
Repligen shares: new convertible debt and the swap of old notes weigh on the stock after hours
- Repligen shares pressure down — a $1 billion convertible notes issue triggered a sharp sell-off after the close
tags
instruments
sources
- Repligen Shares Fall on $1B Note Issuance — Dow Jones Newswires, 6 November 2026 at 22:51 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗